Grants and Contributions:
Title:
000020377
Agreement Number:
000020377
Agreement Value:
$473,500.00
Agreement Date:
Jan 27, 2022 - Mar 31, 2025
Description:
Support sales and marketing of autoimmune disease test for the point-of-care market
Organization:
Pacific Economic Development Canada
Expected Results:
Western Canadian businesses are competitive and export their products/services.
Location:
Vancouver, British Columbia, CA V5T 4T5
Reference Number:
GC-WD-DEO-2021-2022-Q4-241
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
829919521
Recipient Type:
For-profit organization
Recipient's Operating Name:
Augurex Life Sciences Corp
Recipient's Legal Name:
Augurex Life Sciences Corp.
Federal Riding Name:
Vancouver East
Federal Riding Number:
35
Program:
Regional Economic Growth through Innovation
Program Purpose:
Provide streamlined, nationally consistent and yet regionally tailored support for business productivity and scale-up, particularly for small and medium-sized enterprises (SMEs) and women entrepreneurs and other underrepresented groups, and assist the enhancement of regional industrial and technology clusters and regional innovation ecosystems.
NAICS Code:
541710